The company says that if both NRX-101 and NRX-100 are approved, it expects to generate revenue of more than $150 per NRXP share in the near future.
NRx Pharmaceuticals Submits Two New Drug Applications for Depression Treatments NRX-101 and NRX-100
![](https://kawry.co/wp-content/uploads/2024/07/1719856443_onclive_630x1200-860x457.png)
You Might Also Like
Leave a Comment
Latest News
Recent Posts
- How eSIM, IoT and connectivity security are driving Industry 4.0
- Blue Dart opens India’s largest integrated operations facility in Bijwasan, Delhi
- AOKI Mobility launches cutting-edge electric bicycle that realizes sustainable urban transportation
- Taiwan Excellence to showcase next-generation metal processing solutions at IMTEX 2025
- Celebrate love this Valentine’s Day at Amano Covent Garden